Invea Therapeutics, Inc. (INAI)
Invea Therapeutics was planning to go public, but the IPO was withdrawn on Mar 29, 2024.
Stock Price: Pending
IPO price not available yet
Invea Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
7
Market Cap
n/a
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionINAI News
- 13 days ago - Invea Therapeutics Strengthens Leadership with Appointment of Dr. Stephen Doberstein, Veteran Biotech Executive, to Its Board of Directors - GlobeNewsWire
- 1 year ago - Invea Therapeutics Seeks $75 Million U.S. IPO - Seeking Alpha
- 1 year ago - Invea Therapeutics IPO Registration Document (S-1) - SEC